期刊文献+

31例原发性肺类癌的诊治及预后分析 被引量:5

Diagnosis,treatment,and prognostic analysis of thirty-one cases with primary bronchopulmonary carcinoid
下载PDF
导出
摘要 目的:探讨原发性肺类癌的临床病理特征、CT表现、治疗方法及预后。方法:回顾性分析31例原发性肺类癌患者的诊治过程,并对预后行单因素和多因素分析。结果:临床表现:咳嗽、咳痰17例,咯血或痰中带血7例,胸痛、胸闷气短8例,无症状6例。CT表现:圆形或类圆形结节影,界限多清楚,增强可见轻度均匀强化。免疫组织化学检测提示:Syn、CgA、NSE阳性表达率分别为90.3%(28/31)、87.1%(27/31)、90.3%(28/31)。治疗及预后:28例行手术治疗(3例行术后辅助治疗);2例行化疗,1例拒绝治疗。典型和不典型类癌的总体1年生存率分别为100%(18/18)、92.3%(12/13),3年生存率为94.4%(17/18)、69.2%(9/13)。单因素分析示淋巴结转移(P=0.02)、组织类型(P=0.017)、TNM分期(P=0.005)和治疗方法是影响预后的因素(P=0.01)。多因素分析示淋巴结转移(P=0.032)、组织类型(P=0.002)是影响预后的因素。结论:原发性肺类癌的临床及影像表现缺乏特异性,其诊断主要依靠组织病理。手术是其主要且有效的治疗途径,放化疗效果不佳;总体预后较好,但不典型类癌次于典型类癌,病理类型和淋巴结转移情况是影响预后的重要因素。 Objective:We aimed to explore the clinical features, computed tomography (CT) findings, treatment, and prognosis of bronchopulmonary carcinoid. Methods:Clinical data of 31 patients with primary carcinoid tumor of the lung were retrospectively reviewed. The prognostic factors were analyzed via Cox univariate and multivariate analyses. Results: Clinical symptoms included coughing or expectoration in 17 of the 31 cases, hemoptysis or blood-stained sputum in 7 cases, and chest pains or shortness of breath in 8 cases. Six cases were asymptomatic. The CT scans showed round or oval nodules with clear boundaries, and enhancement CT scans indicated mild, homogeneous enhancement. Immunohistochemistry results revealed the positive expression rates of synaptophysin (Syn), chromogranin A (CgA), and neuron-specific enolase (NSE) were 90.3%(28/31), 87.1%(27/31), and 90.3%(28/31), respectively. Therapy and prognosis results were as follows:28 of the total number of patients underwent surgery, among which 3 underwent postoperative adjuvant therapy, 2 received chemotherapy; and only 1 refused treatment. The 1-year overall survival rates were 100%(18/18) and 92.3%(12/13), whereas the 3-year survival rates were 94.4%(17/18) and 69.2%(9/13) in the typical and atypical carcinoid cases, respectively. Cox univariate analysis results revealed that lymphatic metastasis (P=0.02), tissue types (P=0.017), TNM stage (P=0.005), and therapies (P=0.01) were the prognostic factors. Cox multivariate analysis results showed that lymphatic metastasis (P=0.032) and tissue types (P=0.002) were the independent prognostic factors. Conclusion:Compared with other lung cancers, the bron-chopulmonary lung carcinoid has no special clinical manifestation in clinical and radiographic images. The diagnosis was mainly based on histopathology results. Surgery was the main and effective treatment, whereas chemotherapy and radiotherapy showed unsatisfactory results. The overall prognosis was satisfactory. However, the atypical carcinoid was inferior to the typical carcinoid in terms of prognosis. Pathological typing and lymph node metastasis were significant prognostic factors.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第11期724-728,共5页 Chinese Journal of Clinical Oncology
关键词 肺类癌 临床特征 病理 CT表现 预后 bronchopulmonary carcinoid clinical features pathology CT prognosis
  • 相关文献

参考文献3

二级参考文献31

  • 1Di Loreto C,Di Lauro V,Puglisi F,et al.Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma[J].J Clin Pathol,1997,50(1):30-32.
  • 2Folpe A L,Gown A M,Lamps L W,et al.Thyroid transcription factor-1:immunohistochemical evaluation in pulmonary neuroendocrine tumors[J].Mod Pathol,1999,12(1):5-8.
  • 3Ordonez N G.Thyroid transcription factor-1 is a marker of lung and thyroid carcinoma[J].Adv Anat Pathol,2000,7(2):123-127.
  • 4Ordonez N G.Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas[J].Am J Surg Pathol,2000,24(9):1217-1223.
  • 5Agoff S N,Lamps L W,Philip A T,et al.Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors[J].Mod Pathol,2000,13(3):238-242.
  • 6Cheuk W,Kwan M Y,Suster S,et al.Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma,but not pulmonary from extrapulmonary small cell carcinomas[J].Arch Pathol Lab Med,2001,125(2):228-231.
  • 7Al-Khafaji B,Noffsinger A E,Miller M A,et al.Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors[J].Hum Pathol,1998,29(9):992-999.
  • 8Chan J K,Suster S,Wenig B M,et al.Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites[J].Am J Surg Pathol,1997,21(2):226-234.
  • 9Morandi U, Casali C, Rossi G. Bronchial typical carcinoid tumors. Semin Thorac Cardiovasc Surg 2006; 18: 191-198.
  • 10Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L, et al. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 2004; 77: 1781-1785.

共引文献40

同被引文献38

  • 1张宏伟,于春江,孙炜,杨军,闫长祥,寸恩浩.首选溴隐亭治疗侵袭性巨大泌乳素腺瘤的综合治疗[J].中华外科杂志,2006,44(22):1555-1557. 被引量:11
  • 2祁瑾,叶兆祥,肖建宇,白广鑫,战忠利.支气管肺类癌:CT表现与病理对照研究[J].中国肿瘤临床,2007,34(21):1218-1221. 被引量:19
  • 3Hage R,de la Riviere AB,Seldenrijk CA,et al. Update in pulmonary carcinoid tumors:A review article [J]. Ann Surg Oncol, 2003,10(6) : 697-704.
  • 4Lim E, Goldstraw P,Nicholson AG, et al. Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007 [J]. J Thorac Oncol, 2008,3 (10) : 1194-1201.
  • 5Yao JC, Hassan M, Phan A, et al. One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States [J]. J Clin Oncol, 2008,26 (18) : 3063-3072.
  • 6Gustafsson BI, Kidd M, Chan A, et al. Bronchopulmonary neuroendocrine tumors [J]. Cancer, 2008,113 ( 1 ) : 5-21.
  • 7Langhans T. Ueber einen drusenpolyp in ileum [J]. Virhow Arch Pathol Anat Physio Klin Med,1867,38:559- 560.
  • 8Modlin IM,Lye KD,Kidd MA. 5-decade analysis of 13 715 carcinoid tumors [J]. Cancer,2003,97(4):934-959.
  • 9Naalsund A,Rostad H,Strom EH,et al. Carcinoid lung tu- mors-incidence,treatment and outcomes :a population based study [J]. Eur J Cardiothorac Surg,2011,39(4) :565- 569.
  • 10Wirth LJ,Carter MR,Janne PA,et al. Outcome of patients with pulmonary carcinoid tumors receving chemotherapy or chemoradiotherapy [J]. Lung Cancer, 2004, 44: 213-220.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部